New medicine for peanut allergy
Part of Immune system & allergy clinical trials.
This study tests a new medication called LP-003 that may help people with peanut allergy tolerate peanuts better. If you qualify, you might receive the drug or a placebo, and researchers will see if it reduces allergic reactions to peanuts.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 12 to 55 years old.
- You must have a doctor-confirmed peanut allergy, shown by a blood test and a skin prick test.
- You must be able to eat a small amount of peanut (up to 100 mg) during a food challenge without a severe reaction.
- You must agree to avoid peanuts and peanut-containing foods during the study.
- You must not have other serious health conditions like uncontrolled asthma, mast cell disorders, or certain gastrointestinal diseases.
- You must not be pregnant or planning pregnancy, and must use effective birth control during the trial and for 6 months after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase trial tests a new medication, LCA-0061, in healthy people with high IgE levels (a sign of allergies). Part B specifically includes those with a peanut allergy. The study aims to see how safe the drug is and how the body processes it.
This early-phase study tests a new investigational medication (MY006) to see if it is safe and how the body processes it. It is given to both healthy volunteers and people with peanut allergy. The goal is to gather safety information before larger trials.
This study is testing a new blood test for peanut allergy. If you join, you will give a few extra blood samples during a regular blood draw. The test may help doctors better diagnose peanut allergies.
This trial tests an oral (by mouth) immune treatment for people with confirmed peanut allergy. It aims to see whether your immune system can become less reactive to peanuts over time, while keeping you safe during testing with careful emergency planning.
This study tests an investigational medication (LP-003) to see if it can reduce allergic reactions to wheat or gluten. It might help people who currently experience symptoms like hives or stomach problems when they eat these foods.
This trial tests a new peanut allergy treatment called ENP-501. It aims to see if the medicine can safely help people with peanut allergy become less sensitive to peanuts.
Hear when a new Peanut Allergies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.